Texas Permanent School Fund Pfizer Inc Transaction History

Texas Permanent School Fund

$597 Billion
Q3 2024

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 07, 2024	SELL	$25.26 - $29.6 $5.76 Million - $6.75 Million	-228,173 Reduced 19.55%	938,991 $26.3 Million
Q1 2024 May 03, 2024	BUY	$25.89 - $29.73 $35,080 - $40,284	1,355 Added 0.12%	1,167,164 $32.4 Million
Q4 2023 Feb 08, 2024	SELL	$26.13 - $33.94 $20,407 - $26,507	-781 Reduced 0.07%	1,165,809 $33.6 Million
Q3 2023 Nov 09, 2023	SELL	$32.09 - $37.51 $551,242 - $644,346	-17,178 Reduced 1.45%	1,166,590 $38.7 Million
Q2 2023 Aug 07, 2023	BUY	$36.12 - $41.79 $487,222 - $563,705	13,489 Added 1.15%	1,183,768 $43.4 Million
Q1 2023 May 01, 2023	BUY	$39.39 - $51.28 $14.7 Million - $19.1 Million	372,738 Added 46.74%	1,170,279 $47.7 Million
Q4 2022 Feb 07, 2023	BUY	$41.75 - $54.5 $143,160 - $186,880	3,429 Added 0.43%	797,541 $40.9 Million
Q3 2022 Oct 25, 2022	BUY	$43.76 - $53.42 $2.32 Million - $2.83 Million	52,993 Added 7.15%	794,112 $34.8 Million
Q2 2022 Aug 08, 2022	BUY	$46.53 - $55.17 $608,798 - $721,844	13,084 Added 1.8%	741,119 $38.9 Million
Q1 2022 May 06, 2022	SELL	$45.75 - $56.69 $2.06 Million - $2.55 Million	-45,020 Reduced 5.82%	728,035 $37.7 Million
Q4 2021 Feb 08, 2022	SELL	$41.32 - $61.25 $3.85 Million - $5.7 Million	-93,078 Reduced 10.75%	773,055 $45.6 Million
Q3 2021 Oct 28, 2021	SELL	$39.25 - $50.42 $2.5 Million - $3.22 Million	-63,806 Reduced 6.86%	866,133 $37.3 Million
Q2 2021 Jul 27, 2021	SELL	$35.91 - $40.68 $51,028 - $57,806	-1,421 Reduced 0.15%	929,939 $36.4 Million
Q1 2021 May 03, 2021	SELL	$33.49 - $37.77 $1.63 Million - $1.84 Million	-48,663 Reduced 4.97%	931,360 $33.7 Million
Q4 2020 Feb 04, 2021	SELL	$33.47 - $42.56 $2.17 Million - $2.75 Million	-64,700 Reduced 6.19%	980,023 $36.1 Million
Q3 2020 Nov 06, 2020	BUY	$31.75 - $37.25 $2.09 Million - $2.45 Million	65,886 Added 6.73%	1,044,723 $38.3 Million
Q2 2020 Aug 04, 2020	SELL	$30.12 - $36.54 $837,034 - $1.02 Million	-27,790 Reduced 2.76%	978,837 $32 Million
Q1 2020 Apr 27, 2020	BUY	$27.03 - $38.62 $740,081 - $1.06 Million	27,380 Added 2.8%	1,006,627 $32.9 Million
Q4 2019 Feb 03, 2020	SELL	$32.92 - $37.36 $1.68 Million - $1.91 Million	-51,041 Reduced 4.95%	979,247 $38.4 Million
Q3 2019 Oct 31, 2019	SELL	$32.49 - $42.13 $1.31 Million - $1.7 Million	-40,379 Reduced 3.77%	1,030,288 $37 Million
Q2 2019 Aug 09, 2019	SELL	$36.98 - $41.52 $347,501 - $390,163	-9,397 Reduced 0.87%	1,070,667 $46.4 Million
Q1 2019 May 02, 2019	SELL	$37.5 - $41.2 $3.1 Million - $3.4 Million	-82,604 Reduced 7.1%	1,080,064 $45.9 Million
Q4 2018 Feb 11, 2019	SELL	$38.47 - $43.86 $5.9 Million - $6.72 Million	-153,306 Reduced 11.65%	1,162,668 $50.8 Million
Q3 2018 Oct 22, 2018	SELL	$34.47 - $41.81 $3.84 Million - $4.66 Million	-111,460 Reduced 7.81%	1,315,974 $58 Million
Q2 2018 Jul 23, 2018	SELL	$32.98 - $35.16 $3.65 Million - $3.89 Million	-110,658 Reduced 7.19%	1,427,434 $51.8 Million
Q1 2018 Apr 20, 2018	SELL	$31.91 - $37.02 $2.84 Million - $3.3 Million	-89,119 Reduced 5.48%	1,538,092 $54.6 Million
Q4 2017 Jan 23, 2018	SELL	$33.26 - $35.29 $886,645 - $940,760	-26,658 Reduced 1.61%	1,627,211 $58.9 Million
Q3 2017 Nov 13, 2017	BUY	$31.0 - $34.15 $51.3 Million - $56.5 Million	1,653,869	1,653,869 $59 Million

Others Institutions Holding PFE

# of Institutions

3,260

Shares Held

3.61B

Call Options Held

77.2M

Put Options Held

122M

Vanguard Group Inc Valley Forge, PA

516M
Shares

$13.7 Billion
0.27% of portfolio
Black Rock Inc. New York, NY

424M
Shares

$11.3 Billion
0.27% of portfolio
State Street Corp Boston, MA

290M
Shares

$7.73 Billion
0.35% of portfolio
Wellington Management Group LLP Boston, MA

164M
Shares

$4.36 Billion
0.85% of portfolio
Charles Schwab Investment Management Inc San Francisco, CA

130M
Shares

$3.46 Billion
0.73% of portfolio

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $149B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Texas Permanent School Fund, based on Form 13F filings with the SEC.

News

Stay updated on Texas Permanent School Fund with notifications on news.

Account